Overview

Bexarotene in Preventing Breast Cancer in Women at Genetic Risk

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy uses certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether bexarotene is effective in preventing breast cancer. PURPOSE: Randomized clinical trial to study the effectiveness of bexarotene in preventing breast cancer in women who are at genetic risk of developing breast cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Baylor Breast Care Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Bexarotene